source
- BioNTech appoints Sobi CEO Guido Oelkers as new chief, founders to launch separate mRNA biotechBioNTech announced that Guido Oelkers, current chief executive of Swedish Orphan Biovitrum (Sobi), will assume the role of CEO in early 2027. The move follows the earlier decision of co‑founders U…
- BioNTech appoints Guido Oelkers as new CEO, succeeding cofounder Ugur SahinBioNTech announced that Guido Oelkers will become its chief executive officer, taking over from cofounder Ugur Sahin. Oelkers comes from Swedish biopharma Sobi, where he led the company, and bring…